Heng Huang

Shenzhen, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 16 publications

Global urban vegetation exhibits divergent thermal effects: From cooling to warming as aridity increases.

Global urban vegetation exhibits divergent thermal effects: From cooling to warming as aridity increases.

Journal: Science advances

Published: January 02, 2026

Facing a harsh climate: terrestrial plant functional strategies in a changing world.

Facing a harsh climate: terrestrial plant functional strategies in a changing world.

Journal: National science review

Published: October 08, 2025

Widespread controls of precipitation sensitivity on drought recovery of global forests.

Widespread controls of precipitation sensitivity on drought recovery of global forests.

Journal: Nature communications

Published: June 25, 2025

Metronomic capecitabine as extended adjuvant chemotherapy for early triple-negative breast cancer (SYSUCC-001): updated 10-year outcomes and post-hoc exploratory biomarker analysis from a randomised, phase 3 trial.

Metronomic capecitabine as extended adjuvant chemotherapy for early triple-negative breast cancer (SYSUCC-001): updated 10-year outcomes and post-hoc exploratory biomarker analysis from a randomised, phase 3 trial.

Journal: The Lancet. Oncology

Published: June 04, 2025

Effect of intranasal treatment with NAMPT-EVs on acetylated tau and cognitive function in mice with repeated controlled cortical injury.

Effect of intranasal treatment with NAMPT-EVs on acetylated tau and cognitive function in mice with repeated controlled cortical injury.

Journal: International immunopharmacology

Published: May 19, 2025

The overlooked role of root water content in the root economics space.

The overlooked role of root water content in the root economics space.

Journal: Nature plants

Published: April 20, 2025

Metronomic Capecitabine Plus Aromatase Inhibitor as Initial Therapy in Patients With Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer: The Phase III MECCA Trial.

Metronomic Capecitabine Plus Aromatase Inhibitor as Initial Therapy in Patients With Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer: The Phase III MECCA Trial.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: January 02, 2025

The features of male breast cancer in China: A real-world study.

The features of male breast cancer in China: A real-world study.

Journal: Breast (Edinburgh, Scotland)

Published: May 09, 2024

Ductal lavage followed by observation versus oral corticosteroids in idiopathic granulomatous mastitis: A randomized trial.

Ductal lavage followed by observation versus oral corticosteroids in idiopathic granulomatous mastitis: A randomized trial.

Journal: Nature communications

Published: January 09, 2024

Does the Dose of Standard Adjuvant Chemotherapy Affect the Triple-negative Breast Cancer Benefit from Extended Capecitabine Metronomic Therapy? An Exploratory Analysis of the SYSUCC-001 Trial.

Does the Dose of Standard Adjuvant Chemotherapy Affect the Triple-negative Breast Cancer Benefit from Extended Capecitabine Metronomic Therapy? An Exploratory Analysis of the SYSUCC-001 Trial.

Journal: Breast cancer (Dove Medical Press)

Published: November 30, 2023

Global patterns and controlling factors of tree bark C : N : P stoichiometry in forest ecosystems consistent with biogeochemical niche hypothesis.

Global patterns and controlling factors of tree bark C : N : P stoichiometry in forest ecosystems consistent with biogeochemical niche hypothesis.

Journal: The New phytologist

Published: October 04, 2023

Trastuzumab Plus Endocrine Therapy or Chemotherapy as First-line Treatment for Patients with Hormone Receptor-Positive and HER2-Positive Metastatic Breast Cancer (SYSUCC-002).

Trastuzumab Plus Endocrine Therapy or Chemotherapy as First-line Treatment for Patients with Hormone Receptor-Positive and HER2-Positive Metastatic Breast Cancer (SYSUCC-002).

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: September 23, 2021

Showing 1-12 of 16

Last Updated: 09/26/2026